Stay updated on Re-sensitizing Carboplatin-Resistant Ovarian Cancer: FAK Clinical Trial

Sign up to get notified when there's something new on the Re-sensitizing Carboplatin-Resistant Ovarian Cancer: FAK Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Re-sensitizing Carboplatin-Resistant Ovarian Cancer: FAK Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0; the study record remains inaccessible behind a 403 error.
    Difference
    0.2%
    Check dated 2026-11-01T01:57:18.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    A banner announces NIH website transition updates and states that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence.”
    Difference
    1%
    Check dated 2026-10-25T01:56:02.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The site revision in the footer changed from v3.7.1 to v3.7.2. The page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T01:37:57.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T02:09:13.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The study record page now shows a 403 Forbidden error, replacing the detailed study content with a generic error page. This indicates that access to the core trial information is blocked.
    Difference
    20%
    Check dated 2026-09-20T00:55:08.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Revision metadata on the page updated from v3.6.5 to v3.6.6, indicating a newer version of the study details page. This appears to be a maintenance update rather than a change to study data or content.
    Difference
    0.1%
    Check dated 2026-08-29T19:32:02.000Z thumbnail image

Stay in the know with updates to Re-sensitizing Carboplatin-Resistant Ovarian Cancer: FAK Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Re-sensitizing Carboplatin-Resistant Ovarian Cancer: FAK Clinical Trial page.